Coherus Oncology Inc (CHRS)

Operating Cash Flow Growth

-157.28%

Quarterly · Period ending:

CHRS logo

CHRS Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-157.28%
CHRS Quarterly Cash from Operations YoY % (308.94% → -157.28%)
High-resolution chart · PNG

CHRS operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
-157.2826%
-124.1385%
-168.9178%
25.279%
-178.0661%
44.7761%
321.1332%
-14.2099%
253.4987%
31.9589%
87.0569%
-46.4046%
22.2276%
-27.1755%
-91.0344%
-370.5054%
-26,515.4255%
-4,053.5479%
-257.958%
-71.0451%
-100.3123%
-89.8568%
87.0356%
-13.8269%
374.8048%
123.6509%
137.3921%
228.4232%
135.6797%
-69.6731%
-58.2882%
-3.0737%
36.0672%
54.1684%
65.5641%
32.9873%
-102.9063%
3.9821%
-1,660.8407%
-3.8438%
-31.4251%
-130.8269%
116.7253%
-1,053.8685%
-9,503.6866%
-324.2252%
-767.5692%
-124.0175%
94.6181%
308.9415%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.